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ABSTRACT 
Background: Type 2 diabetes is a common chronic disease resulting from a 
complex inheritance-environment interaction along with other risk factors 
such as obesity and sedentary lifestyle. Type 2 diabetes and its complications 
constitute a major worldwide public health problem, affecting almost all 
populations in both developed and developing countries like India with high 
rates of diabetes-related morbidity and mortality. Method: 110 women 
volunteers of age 35 to 55 years depending upon body mass index, were 
divided into five groups. Control – (BMI < 25 kg / m2), Group I (BMI 25-
29.9 kg / m2), Group II (BMI 30-34.9 kg / m2), Group III (BMI 35-39.9 kg / 
m2), Group IV (BMI > 40 kg / m2) were selected as subjects.  Their Body 
Mass Index, Waist – Hip circumference ratio (W/H), Fasting blood sugar 
(FBS), lipid profile: serum triglycerides (TG), serum total cholesterol and 
HDL, VLDL cholesterol were assessed. Result: There is a close association 
between obesity and type 2 diabetes. The mean values of FBS, HDL, TG & 
VLDL are significantly higher in group I compared to controls. The mean 
values of W/H ratio, FBS, HDL, TG & VLDL are higher in group II, III and 
IV compared to controls. Conclusion: In the middle aged women obesity is 
the major factor which increases the risk for diabetes. Obesity plays a role by 
altering homeostasis of the body; it does this by bringing about the changes 
in the various parameters studied. 
KEYWORDS:  Middle aged women; Obesity; Type-2 diabetes mellitus 
 
INTRODUCTION  
 It is estimated that diabetes affects 387 million people 
worldwide [1]. Obesity has risen to epidemic proportions 
in India, leading to an emerging epidemic of type 2 
diabetes. It is a particular problem among middle aged 
women, half of whom are obese (BMI ≥30 kg/m2) [2]. 
Type 2 diabetes mellitus is characterized by 
hyperglycemia, insulin resistance and relative impairment  
 
 
 
in insulin secretion[3]. The pathogenesis of type 2 diabetes 
is poorly understood, but is heterogeneous and both 
genetic factors affecting insulin release and 
responsiveness and environmental factors, such as 
obesity, are important [4]. The prevalence of diabetes 
increases with age and reached a peak in the 60–64 age 
groups [5]. Systolic blood pressure (SBP), waist–hip ratio 
and family history of diabetes were the most significant 
risk factors for type 2 diabetes. The adjusted analysis 
model indicated that women with early menopause (45 
years of age) were 3.4-fold and 2.7-fold more likely to 
suffer from type 2 diabetes and pre-diabetes respectively 
in comparison to women with normal age at menopause[6]. 
More attention should be given to elderly women with 
early menopause, elevated systolic blood pressure and 
increased obesity-related measures, who are at high risk 
of pre-diabetes and type 2 diabetes [7]. Studies of whites 
indicate that central or abdominal obesity is an 
independent risk factor for diabetes, but there have been 
no data on middle aged women. So we planned to see the 
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effect of obesity on type 2 diabetes in middle aged 
women. 
METERIALS AND METHODS 
Study design: An Observational study 
Ethics approval: Written informed consent was obtained 
from the each participant and Institutional Ethical 
Committee permission was taken. 
Study location: The study was conducted at Department 
of physiology, MNR Medical College & Hospital, 
Sangareddy.  
Study period: The period June 2015 to January 2016.  
Sample size: 110 volunteer women of age 35 to 55 years 
were selected as subjects. Baseline examination was 
performed  
Inclusion criteria: Only female subjects with BMI. 25 
Kg/m2, with no family history of diabetes and with no 
history of cardiovascular diseases are selected. 
Exclusion criteria: Subjects with past history of smoking 
and alcohol intake and subjects with family history of 
diabetes and hypertension. 
Grouping:  According their BMI values participants 
were divided into 5 groups as mentioned below 
METHODS 
Body Mass Index calculation: Standing height, weight 
was recorded without shoes and with light clothes by 
using a Krups weighing machine with a least count of 100 
gm. 
BMI was calculated by the formula: BMI = weight (kg) / 
height (mt2). 
Table 1: WHO classification of obesity [8]. 
Grouping Weight BMI ( kg /mt2) 
Control Normal weight 18.5 – 24.9 
Group I Over weight  25.0 – 29.9 
Group II Class I Obesity 30.0 – 34.9 
Group III Class II Obesity 35.0 – 39.9 
Group IV Class III Obesity  40.0 
Waist – Hip circumference ratio (W/H) estimation [9] 
was measured by using a graduated tape when subjects 
were in a standing position. Waist circumference was 
obtained at the level midway between the lower rib 
margin and iliac crest while the subjects breathe out 
gently. Hip circumference was taken at the level of 
maximal gluteal protrusion. Waist hip ratio was 
calculated by dividing waist circumference by Hip 
circumference. 
Blood pressure: Resting BP was recorded as the first and 
fifth and fifth Korottkoff sound by auscultatory methods 
in sitting position with sphygmomanometer from the right 
arm of the subject who were asked to sit for 5 minutes 
before the measurement. The mean of three 
measurements was used in the analysis [10]. 
Blood glucose: Glucometer was used to estimate the 
blood glucose level. Glucose value was expressed as 
mg/dl or mmol/l [11].  
Study of Lipid profile: Collection of blood sample: 
After overnight fasting for 12 hrs, from each subject 3 ml 
of blood was obtained from cubital vein in a clean dry 
bottles containing EDTA. After 1 hr the serum was 
separated by centrifugation. From the serum the following 
parameters were estimated: Serum cholesterol, serum 
triglyceride and serum HDL cholesterol [12]. 
VLDL cholesterol = It is calculated by Totalcholesterol / 
5.LDL cholesterol = it is calculated by Total cholesterol – 
(HDL cholesterol + VLDL cholesterol) 
 
RESULTS  
The present study revealed that the mean values of waist 
hip ratio, fasting blood sugar, total cholesterol, 
triglycerides, and VLDL of obese women of group I, II, 
III and IV showed statistically highly significant increase. 
The mean values of LDL of obese women of group III & 
IV showed statistically significant and highly significant 
increase in values respectively. The mean values of pulse 
rate of obese women of group I, II, III, IV showed 
statistically insignificant increase in values. The mean 
values of SBP of obese women of group I, II, III showed 
increase in values but were found statistically 
insignificant. In group IV showed statistically highly 
significant increase in values. The mean values of DBP of 
obese women of group I, II, III, IV showed increase in 
values. In group IV showed statistically highly significant 
increase in values.   
The mean values of FBS, HDL, and TG& VLDL are 
significantly higher in group I when compared with 
control  The mean values of pulse rate, SBP, DBP W/H 
RATIO, FBS, TC, HDL, TG, LDL and VLDL are 
significantly higher in group II when compared with 
control. Within group III, the mean values of W/H 
RATIO, FBS, HDL,TG and VLDL  are higher with more 
significance (p<0.01). The mean values of TC and LDL 
are higher with less significance (p<0.05).The mean 
values of Pulse rate, SBP, DBP W/H RATIO, FBS, TC, 
HDL, TG, LDL and VLDL are significantly higher in 
group II when compared with control. Within group IV, 
the mean values of BMI,W/H RATIO, FBS, HDL,TG and 
VLDL  are higher with more significance (p<0.01). The 
mean values of TC and LDL are higher with less 
significance (p<0.05). 
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Table 2: Comparison of various parameters control and group I, II, III and IV 
Parameters Controls Group I  Group II Group III Group IV 
Pulse rate 75.65±7.84 75.80 ± 4.62 76.08 ± 5.82 76.51 ± 5.15 77.86±4.53 
SBP (mm/Hg) 110.20± 7.81 121.33±13.05 121.6± 14.83 126.66± 11.55 144.52 ±10.3*** 
DBP(mm/Hg) 74.26 ±5.69 76.48 ± 7.39 78.25 ± 9.33 82.60 ± 9.42 86±5.45*** 
W/H RATIO 0.77 ±0.025 0.78 ± 0.02 0.81 ± 0.03*** 0.85 ± 0.04*** 0.88±0.01*** 
FBS(mg/dl) 90.73 ± 13.64 151 ± 41.99*** 160.5±44.6*** 196.83±57.4*** 200.6±34.8*** 
TC (mg/dl) 150.33 ± 43.24 177.86± 36.74 179.77 ± 40.08 182.47 ± 33.28* 186.8±37.33 
HDL(mg/dl) 46.58 ±7.38 44.35±10.57** 42.60 ± 10.32 40.58 ± 10.43** 39.21± 6.65** 
TG(mg/dl) 110.93 ± 28.40 162±102.67** 169±104.8*** 179.3±47.4*** 209.8±29.5*** 
LDL(mg/dl) 91.69 ±35.04 97.01 ± 21.14 99.03 ± 25.95 100.07 ± 22.96* 144.46±9.87** 
VLDL(mg/dl) 22.6 ±6.27 27.77±21.11** 32.31±20.37** 34.52 ± 8.75** 39.23± 6.06*** 
Values are expressed as mean±SD.* P<0.05** p <0.01, *** p <0.001, All values are compared with control groups. 
DISCUSSION 
The proportions of people with type 2 diabetes and 
obesity have increased throughout Asia, and the rate of 
increase shows no sign of slowing. People in Asia tend to 
develop diabetes with a lesser degree of obesity at 
younger ages, suffer longer with complications of 
diabetes and die sooner than people in other regions. 
According to Yogesh Saxena et al [12]., childhood obesity 
has increased substantially and the prevalence of type 2 
diabetes has now reached epidemic levels in Asia. The 
health consequences of this epidemic threaten to 
overwhelm health-care systems in the region4. Urgent 
action is needed and advocacy for lifestyle changes is the 
first step. Countries should review and implement 
interventions and take a comprehensive and integrated 
public-health approach.  
Diabetes has been known in India for centuries as a 
disease of the affluent class. India faces a grave health 
care burden due to the high prevalence of type 2 diabetes 
and its sequelae, as a result of societal influences and 
changing lifestyle[13]. Obesity is one of the potentially 
modifiable risk factor for type 2 diabetes [13]. The results 
of the present study are in line with these earlier studies 
and indicate that the obesity alters body homeostasis and 
probably results in metabolic changes leading to the 
increased risk of diabetes. Many intervention studies have 
proven that, modest weight loss has been achieved by 
lifestyle interventions in overweight subjects with 
impaired glucose tolerance [14]. It is well established that 
those developing type 2 diabetes have a higher body 
weight than control populations reflecting the strong 
epidemiological association between obesity and the 
development of diabetes[15]. Our results prove this 
statement. 
In contrast, much less attention has been paid to the 
significance of obesity in clinic populations with diabetes. 
Obesity is an independent risk factor for cardiovascular 
and other metabolic diseases[16]. In type 2 diabetes, weight 
loss has a beneficial effect on indices of glycaemic control 
and treatment requirements and those who achieve 
pronounced weight loss experience normalization of 
insulin sensitivity and blood glucose concentrations[17]. In 
clinical practice this is best exemplified by bariatric 
surgery in obese type 2 diabetic patients, which often 
leads to enduring remission of the disease[18].  
CONCLUSION 
The relationship between obesity and diabetes mellitus 
has been reported to be age and gender dependent. 
However, this relationship has not been extensively 
studied in middle aged women in India. Clarification of 
this issue may help us to create more effective public 
awareness on diabetes mellitus via weight control. The 
present study results will definitely add to this aspect and 
help to take preventive measures in middle aged women.  
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